MAPT and Alzheimer disease: We showed that injection of AD P-tau into the hippocampi of Tg/hTau and 3xTg-AD mice induces AD-like NFTs, which can be labeled by various phosphorylation-dependent and site-specific anti-tau antibodies (Hu et al., 2016; Dai et al., 2018).